Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
USD 25.04
(-1.14%)
USD 25.04
(-1.14%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 580 Thousand USD | 133.22% |
| 2022 | -1.74 Million USD | -514.79% |
| 2021 | -284 Thousand USD | 82.6% |
| 2020 | -1.63 Million USD | -224.45% |
| 2019 | -503 Thousand USD | 90.36% |
| 2018 | -5.21 Million USD | 57.11% |
| 2017 | -12.16 Million USD | 23.42% |
| 2016 | -15.88 Million USD | -7.15% |
| 2015 | -14.82 Million USD | -46.08% |
| 2014 | -10.14 Million USD | -32.0% |
| 2013 | -7.68 Million USD | -83.95% |
| 2012 | -4.17 Million USD | -344.93% |
| 2011 | -939.22 Thousand USD | 62.47% |
| 2010 | -2.5 Million USD | 45.17% |
| 2009 | -4.56 Million USD | -21.83% |
| 2008 | -3.74 Million USD | -31.02% |
| 2007 | -2.85 Million USD | -6088.35% |
| 2006 | -46.2 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 1.53 Million USD | 122.08% |
| 2024 Q1 | -6.92 Million USD | -54.13% |
| 2023 Q1 | -1.46 Million USD | 17.55% |
| 2023 Q2 | 2.35 Million USD | 260.44% |
| 2023 Q4 | -4.49 Million USD | -357.74% |
| 2023 FY | 580 Thousand USD | 133.22% |
| 2023 Q3 | 1.74 Million USD | -25.85% |
| 2022 Q3 | -94 Thousand USD | -105.56% |
| 2022 Q4 | -1.77 Million USD | -1791.49% |
| 2022 Q1 | -785 Thousand USD | 55.27% |
| 2022 Q2 | 1.69 Million USD | 315.29% |
| 2022 FY | -1.74 Million USD | -514.79% |
| 2021 FY | -284 Thousand USD | 82.6% |
| 2021 Q2 | 4.16 Million USD | 42.92% |
| 2021 Q1 | 2.91 Million USD | 11.08% |
| 2021 Q3 | -3.71 Million USD | -189.16% |
| 2021 Q4 | -1.75 Million USD | 52.78% |
| 2020 Q4 | 2.62 Million USD | 64.43% |
| 2020 FY | -1.63 Million USD | -224.45% |
| 2020 Q2 | -3.21 Million USD | -411.15% |
| 2020 Q1 | -628 Thousand USD | -168.41% |
| 2020 Q3 | 1.59 Million USD | 149.75% |
| 2019 Q1 | -556 Thousand USD | 74.29% |
| 2019 FY | -503 Thousand USD | 90.36% |
| 2019 Q2 | -767 Thousand USD | -37.95% |
| 2019 Q3 | -4.39 Million USD | -473.4% |
| 2019 Q4 | 918 Thousand USD | 120.87% |
| 2018 Q2 | -624 Thousand USD | 64.96% |
| 2018 Q1 | -1.78 Million USD | 17.2% |
| 2018 FY | -5.21 Million USD | 57.11% |
| 2018 Q4 | -2.16 Million USD | -233.28% |
| 2018 Q3 | -649 Thousand USD | -4.01% |
| 2017 Q2 | -3.01 Million USD | 28.69% |
| 2017 Q1 | -4.23 Million USD | -20.61% |
| 2017 Q4 | -2.15 Million USD | 22.18% |
| 2017 Q3 | -2.76 Million USD | 8.39% |
| 2017 FY | -12.16 Million USD | 23.42% |
| 2016 Q3 | -4.61 Million USD | -15.07% |
| 2016 Q2 | -4 Million USD | -6.77% |
| 2016 Q1 | -3.75 Million USD | 20.04% |
| 2016 Q4 | -3.5 Million USD | 23.94% |
| 2016 FY | -15.88 Million USD | -7.15% |
| 2015 Q3 | -3.52 Million USD | -1.38% |
| 2015 FY | -14.82 Million USD | -46.08% |
| 2015 Q4 | -4.69 Million USD | -33.04% |
| 2015 Q2 | -3.48 Million USD | -11.68% |
| 2015 Q1 | -3.11 Million USD | -13.35% |
| 2014 FY | -10.14 Million USD | -32.0% |
| 2014 Q1 | -2.33 Million USD | -23.35% |
| 2014 Q2 | -2.6 Million USD | -11.45% |
| 2014 Q3 | -2.45 Million USD | 5.55% |
| 2014 Q4 | -2.74 Million USD | -11.86% |
| 2013 Q4 | -1.89 Million USD | 9.4% |
| 2013 Q3 | -2.08 Million USD | 6.32% |
| 2013 Q2 | -2.23 Million USD | -51.51% |
| 2013 Q1 | -1.47 Million USD | -0.95% |
| 2013 FY | -7.68 Million USD | -83.95% |
| 2012 Q4 | -1.45 Million USD | -16.69% |
| 2012 Q1 | -351.91 Thousand USD | -12.38% |
| 2012 Q2 | -1.11 Million USD | -217.77% |
| 2012 Q3 | -1.25 Million USD | -11.78% |
| 2012 FY | -4.17 Million USD | -344.93% |
| 2011 Q3 | -66.49 Thousand USD | 54.38% |
| 2011 FY | -939.22 Thousand USD | 62.47% |
| 2011 Q2 | -145.76 Thousand USD | 64.78% |
| 2011 Q1 | -413.82 Thousand USD | -1.61% |
| 2011 Q4 | -313.14 Thousand USD | -370.92% |
| 2010 Q1 | -870.74 Thousand USD | -12.13% |
| 2010 FY | -2.5 Million USD | 45.17% |
| 2010 Q2 | -496.76 Thousand USD | 42.95% |
| 2010 Q4 | -407.28 Thousand USD | 44.04% |
| 2010 Q3 | -727.77 Thousand USD | -46.5% |
| 2009 Q2 | -1.23 Million USD | 24.43% |
| 2009 FY | -4.56 Million USD | -21.83% |
| 2009 Q4 | -776.52 Thousand USD | 16.43% |
| 2009 Q3 | -929.23 Thousand USD | 24.47% |
| 2009 Q1 | -1.62 Million USD | -68.82% |
| 2008 Q2 | -1.28 Million USD | -91.98% |
| 2008 Q3 | 834.67 Thousand USD | 165.19% |
| 2008 Q4 | -964.35 Thousand USD | -215.54% |
| 2008 FY | -3.74 Million USD | -31.02% |
| 2008 Q1 | -666.95 Thousand USD | 57.08% |
| 2007 FY | -2.85 Million USD | -6088.35% |
| 2007 Q3 | 969.14 Thousand USD | 87489.0% |
| 2007 Q1 | -1897.00 USD | 34.65% |
| 2007 Q2 | -1109.00 USD | 41.54% |
| 2007 Q4 | -1.55 Million USD | -260.33% |
| 2006 Q4 | -2903.00 USD | 62.46% |
| 2006 FY | -46.2 Thousand USD | 0.0% |
| 2006 Q3 | -7733.00 USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -13.47 Million USD | 104.303% |
| BIMI International Medical Inc. | -15.33 Million USD | 103.781% |
| China Jo-Jo Drugstores, Inc. | -3.53 Million USD | 116.409% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 431 Thousand USD | -34.571% |
| Leafly Holdings, Inc. | -7.05 Million USD | 108.226% |
| Leafly Holdings, Inc. | -7.05 Million USD | 108.226% |
| LifeMD, Inc. | -14.48 Million USD | 104.003% |
| LifeMD, Inc. | -14.48 Million USD | 104.003% |
| TRxADE HEALTH, Inc. | -7.26 Million USD | 107.985% |
| PetMed Express, Inc. | -8.16 Million USD | 107.106% |
| Walgreens Boots Alliance, Inc. | -14.07 Billion USD | 100.004% |